Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03323099 · ClinicalTrials.gov registry record · NA
Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 499
- Enrollment target
NCT03323099 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 499 participants.
The verdict
NCT03323099, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 499 participants
- Enrollment target
Study Summary
The I-STOP-Afib study will test the comparative effectiveness of using N-of-1 trials vs. symptom surveillance alone to reduce Atrial Fibrillation (AF) episode frequency and severity and improve quality of life for AF patients. The study will involve randomizing almost 500 paroxysmal AF patients to either AF episode tracking versus engaging in testing the relationship between participant-selected triggers and AF episodes utilizing a mobile-app based N-of-1 study design. Both groups will complete a validated survey to assess AF severity, essentially a measure of quality of life while living with AF, before and after a 3 month testing period.
Interventions
- BEHAVIORAL N-of-1
- BEHAVIORAL Data Tracking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2020-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03323099
The ClinicalTrials.gov registry entry for NCT03323099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which N-of-1 is the first listed.
NCT03323099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03323099 about?
NCT03323099 is a clinical study titled "Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation". The I-STOP-Afib study will test the comparative effectiveness of using N-of-1 trials vs. symptom surveillance alone to reduce Atrial Fibrillation (AF) episode frequency and severity and improve quality of life for AF patients. The study will involve randomizing almost 500 paroxysmal AF patients to e...
What is the current status of trial NCT03323099?
This trial is currently completed. It is a NA study. The enrollment target is 499 participants. The study started on 2019-03-20. Estimated completion is 2020-04-03.
What interventions are being tested in trial NCT03323099?
The interventions under investigation include: N-of-1 (BEHAVIORAL), Data Tracking (BEHAVIORAL).
Who is sponsoring clinical trial NCT03323099?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.